PolarityTE to Attend H.C. Wainwright 23rd Annual Global Investment Conference and 2021 Cantor Virtual Global Healthcare Conference
07 September 2021 - 10:00PM
Business Wire
PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company
developing regenerative tissue products and biomaterials, announced
today that it will present at the H.C. Wainwright 23rd Annual
Global Investment Conference on September 13, 2021 and participate
in a fireside chat at the 2021 Cantor Virtual Global Healthcare
Conference on September 28, 2021.
A live audio webcast of the H.C. Wainwright 23rd Annual Global
Investment Conference on September 13, 2021 at 7:00 a.m. Eastern
Time will be accessible in real time on the "News &
Media/Events" section of PolarityTE's website at
www.polarityte.com/news-media/events or via the following link:
Link to Webcast
A live audio webcast of the 2021 Cantor Virtual Global
Healthcare Conference on September 28, 2021 at 11:20 a.m. Eastern
Time will be accessible in real time on the "News &
Media/Events" section of PolarityTE's website at
www.polarityte.com/news-media/events or via the following link:
Link to Webcast
About PolarityTE®
PolarityTE is focused on transforming the lives of patients by
discovering, designing, and developing a range of regenerative
tissue products and biomaterials for the fields of medicine,
biomedical engineering and material sciences. Rather than
manufacturing with synthetic and foreign materials within
artificially engineered environments, PolarityTE manufactures
products from the patient's own tissue and uses the patient's own
body to support the regenerative process. From a small piece of
healthy autologous tissue, the company creates an easily
deployable, dynamic, and self-propagating product designed to
regenerate the target tissues. PolarityTE's innovative methods are
intended to promote and accelerate growth of the patient's tissues
to undergo a form of effective regenerative healing. PolarityTE’s
products, including SkinTE, are in the development stage, and are
not approved or available for clinical use. Learn more at
www.PolarityTE.com – Welcome to the Shift®.
Forward Looking Statements
Certain statements contained in this release are
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. They are generally
identified by words such as "believes," "may," "expects,"
"anticipates," "intend," "plan," "will," "would," "should" and
similar expressions. Readers should not place undue reliance on
such forward-looking statements, which are based upon the Company's
beliefs and assumptions as of the date of this release. The
Company's actual results could differ materially due to the impact
of the COVID-19 pandemic, future clinical studies, and FDA
regulatory matters, which cannot be predicted, and the risk factors
and other items described in more detail in the "Risk Factors"
section of the Company's Annual Reports and other filings with the
SEC (copies of which may be obtained at www.sec.gov). Subsequent
events and developments may cause these forward-looking statements
to change. The Company specifically disclaims any obligation or
intention to update or revise these forward-looking statements as a
result of changed events or circumstances that occur after the date
of this release, except as required by applicable law.
POLARITYTE, the POLARITYTE logo, SKINTE, WHERE SELF REGENERATES
SELF and WELCOME TO THE SHIFT are registered trademarks of
PolarityTE, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210907005241/en/
Investors: Rich Haerle VP, Investor Relations PolarityTE,
Inc. ir@PolarityTE.com (385) 315-0697
PolarityTE (NASDAQ:PTE)
Historical Stock Chart
From Apr 2024 to May 2024
PolarityTE (NASDAQ:PTE)
Historical Stock Chart
From May 2023 to May 2024